Liver transplantation
Conditions
Interventions
Experimental group:Icaritin combined with TKI
Sponsors
The Affiliated Hospital of Qingdao University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >=18 years old, male or female; 2. Patients with recurrence of liver cancer after liver transplantation and those with high risk factors after transplantation need drug prevention; 3. Hepatocellular carcinoma meets clinical diagnostic criteria and/or is confirmed by histopathological examination; 4. Contains at least one target lesion whose size and enhanced area can be accurately measured on dynamic enhanced CT or MRI; 5. Subjects were willing to accept Icaritin-based treatment; 6. Subjects volunteered to participate in the project.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women; 2. In the clinician's judgment, the patient was not suitable for inclusion in other conditions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PFS; | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 year OS rate;Safety; | — |
Countries
China
Contacts
Public ContactWei Rao
The Affiliated Hospital of Qingdao University
Outcome results
None listed